Antimicrobial Resistance (AMR)

Slides:



Advertisements
Similar presentations
European Antibiotic Awareness Day 2013, 18 November 2013 European Antibiotic Awareness Day 2013 * Joining efforts to avoid a post-antibiotic era [Name.
Advertisements

Combatting Antimicrobial Drug Resistance Dr Charles Penn Pandemic and Epidemic Diseases Health Security and Environment.
Lobbying for Food Security: FAO advocacy interventions
Antimicrobial resistance “One health fits all”
Antibiotic Policy in Ghana; the way forward
Technical Advisory Group meeting, WHO/WPRO
Essential Drugs Programme
| Antimicrobial Resistance Global Report on Surveillance 2014 Global Action Plan to combat antimicrobial resistance.
The Work of WHO in the South-East Asia Region The Work of WHO in the South-East Asia Region Biennial Report of the Regional Director 1 January
EQUI - TB Knowledge Programme Quality Assured TB Care for Poor People in Resource Constrained settings 2001 – 2006 Purpose: To promote implementation of.
Tools for HIV/TB Integration and the Civil Society Experience Carol Nawina Nyirenda Executive Director Community Initiative for Tuberculosis, HIV/AIDS.
Claire Boville – Department of Health
PAHO Pan American Health Organization Pan American Sanitary Bureau Regional Office for the Americas for the World Health Organization.
Public-Private Partnerships -Selected Experiences in the Western Pacific & Cambodia- National Forum on Public-Private Partnership in Health 7 November,
Surveillance of antimicrobial use in resource-constrained community settings Kathleen Holloway, Elizabeth Mathai and Andy Gray on behalf of on behalf of:
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Barriers to achieving the health MDGs and how these can be overcome Action for Global Health UK Policy Conference London, 28 June 2010 Isabelle de Zoysa.
"Addressing Violence against Women in HIV Responses in Eight Countries Worldwide" Dr Jantine Jacobi, UNAIDS/GCWA New York, 29 February.
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver” Elizabeth J. Phillips, MD, FRCPC,FRACP, FACTM Professor & Director, Centre for Clinical.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Pandemic Preparedness Rome | June |1 | Pandemic Preparedness FAO/ OIE/ WHO Technical Meeting on Highly Pathogenic Avian Influenza, June,
The AMR One Health Policy Toolkit: Animal - Human Interface Dr Mark Schipp December 2014.
1 Combating Drug Resistance Syed Khalid Saeed Bukhari.
EC actions against the rising threats from Antimicrobial Resistance
Ministerial Declaration and Concluding Remarks MD PhD Karin Tegmark Wisell Chair AMR expert group, NDPHS.
2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.
1. SUSTAINABLE ANIMAL PRODUCTION The future of the farmers 2.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Susan Sparkes Department of Health System Governance and Financing, WHO Financing for universal health coverage: What does this mean for ending the HIV.
WHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections Common structure Universal Health Coverage SDGs Cascade.
WHO Regional Office for Europe
AMR containment in Thailand
Antibiotic Policy in Ghana; the way forward
Public-Private Partnerships: Livestock Sector Development Programmes
ACCESS TO QUALITY MEDICINES IN THE REGION-COUNTERFEITING PROBLEMS
Introduction to Antimicrobial Resistance
WHO’s prioritised research agenda for the prevention and control of NCDs prioritises
FAO Food Safety Programme
EMR Consultation, HRH Observatory, Tunis, September 2010
Business sector engagement and Consumer Awareness October 3rd, 2017
Professor Alan Johnson Department of HCAI & AMR
Review of integrated PSM resources and tools and introduction to group work Upjeet Chandan ICCM FTT 17th February 2016.
Access Equity in Prisons in Africa A CALL FOR ACTION
Declaration of the 11th ministerial-level PAC meeting in Berlin 2015 From strategies to action – how to tackle the challenges of Antimicrobial Resistance.
National health policy review
Call topic identification for 2019 call
Antimicrobial Resistance: Plans for Korea and Beyond
08 Uniting the World against AIDS Introduction
Antibiotic Resistance: Strategic Solutions
Knowledge gaps in formulating TB Control Policies for Prisons
“An overview” 10th April 2018 at MOH SMT Now 27th April 2018 at NPHIL
WHO 2015 GUIDELINES AND FAST TRACKING TOWARDS : Regional perspective
World Health Organization
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver”
Essential Drugs and Medicines Policy
Regional workshop on Approaches to the implementation and monitoring of community-based ecosystem approach to fisheries management (CEAFM): finding common.
World Health Day 2011.
Essential Drugs and Medicines Policy
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
Millennium Development Goals (MDGs)
The STOP TB Strategy – 2009 VISION: A TB-free world
Антибиотикийн тэсвэржилт- дэлхий нийтийн тулгамдсан асуудал
SRIA Roadmap Jonathan Pearce
SUSTAINABLE TOURISM HANDBOOK FOR EASTERN AFRICA: Aims and objectives
An Enabling Business Environment and A Strategic Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
An Enabling Business Environment and A Strategy and Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
Antimicrobial Resistance
National one Health Strategy( )
Antimicrobial Resistance
SDGs Learning and Information Platforms:
Presentation transcript:

Antimicrobial Resistance (AMR) Dr Ali Ahmed Yahaya, WHO-Regional Office for Africa-AFRO Brazzaville-Congo

What is AMR? AMR is a natural phenomenon accelerated by use of antimicrobial medicines. Medicines for treating infections lose effect because the microbes change Mutate Acquire genetic information from other microbes to develop resistance Types of AMR 1. Antibacterial resistance (e.g. to antibiotics) 2. Antiviral resistance (e.g. to anti-HIV medicines) 3. Antiparasitic resistance (e.g. to anti-malaria medicines) 4. Antifungal resistance (e.g. to medicines for Candidiasis) AMR in the African region

Benefits of antimicrobial medicines have been enormous Penicillin increased survival from 10% to 90% among patients with pneumonia & bacteria in their blood AMR in the African region

Resistance was foreseen early “The time may come when penicillin can be bought by anyone in the shops. Then there is the danger that the ignorant man may easily under dose himself and by exposing his microbes to non-lethal quantities of the drug make them resistant” Alexander Fleming, Nobel Lecture, December 1945 AMR in the African region

Survey of 114 countries in all regions 2014 WHO report “Antimicrobial resistance: global report on surveillance” Survey of 114 countries in all regions 23 countries in AFR Data limitations Surveillance gaps in many countries No standard methodology But best available global & regional pictures In all regions, very high AMR levels in common bacteria to major antibiotics E coli, K pneumoniae, S aureus, S pneumoniae, N gonorrhea 3rd generation cephalosporins, fluoroquinolones, methicillin

Available National Data Available National Data* on Resistance for Nine Selected Bacteria/Antibacterial Drug Combinations, 2013 Data is Patchy High reported proportions of resistance means that treatment for severe infections, for which E. coli & k. pneumoniae are a likely cause, may need to be initiated with expensive therapy AMR in the African region

Resistance was foreseen early Extensively drug-resistant TB (XDR-TB) had been reported by 92 countries by the end of 2012 AMR in the African region

AMR – Why is it increasing? Circulation of substandard counterfeit antimicrobials Weak IPC : spread of MDR health care associated infections in health care facilities Spread and contamination of the environment (hospital wastewaters, un-completely treated urban wastewaters, untreated effluents from livestock farms or aquaculture) Antibiotics fed to animals to promote growth in some countries Antibiotic resistance is a complex problem with many drivers combating it requires a multifaceted approach AMR in the African region

Consequences Implications Projections AMR in the African region

AMR Global Action Plan (GAP) Adopted by World Health Assembly in May 2015 Technical blueprint on what to do Consolidates global scientific consensus & draws upon countries, FAO, OIE, civil society & others Reflects stepwise approach recognizing countries have different starting points, priorities AMR in the African region

Five strategic objectives Improve awareness and understanding Strengthen knowledge through surveillance & research Reduce incidence of infection (IPC\Sanitation) Optimize use of antimicrobial medicines Ensure sustainable investment 1 2 3 4 5 Next step to translate into National Action Plans AMR in the African region

Implementation GAP: Guiding Principles Realistic & achievable objectives Take into account different capacities of Member States Involve FAO and OIE, where appropriate All-inclusive approach (HIV, TB and malaria) Joint ownership between HQ and Regions Communication! AMR in the African region

Implementation GAP: 10 work streams (HQ & AFRO) Global communications campaign Support National Action Plans of MS Global Antimicrobial Resistance Surv System Support measures to improve IPC Monitor use & enhance stewardship of antibiotic use Encourage R and D and explore new business models Improve Point of Care diagnostics Address the Environmental Drivers Vaccines to prevent AMR One Health Liaison AFRO inter-clusters/programms Workforce. AMR in the African region

AFRO major achievements 9 countries trained on the development of AMR-National Action Plan using “One Health Approach”. Epidemiologists and laboratory scientists from national institutions representing food, animal and human health sectors from the 13 countries participated in the Global Antimicrobial Resistance Surveillance System (GLASS) training. 12 countries participated in the training workshop on methodology for monitoring antimicrobial consumption. AMR in the African region

Major issues and challenges Lack of a national comprehensive policy and plan (NAP) to address AMR Lack of inter-sectorial approach to fight AMR Weak medicines regulatory capacity and circulation of substandard/counterfeit antimicrobials Medicines supply and distribution systems in most countries of the Region are fragmented and weak Weak Infection Prevention and Control (IPC) AMR in the African region

Conclusion AMR now an urgent, global, Large problems, societal threat– e.g., climate change — require whole-of-society engagement & strategies & solution commensurate with scope Adopting & acting upon a broader concept of AMR is essential to achieving such an approach & sustainably reversing AMR Opportunities for existing and new initiatives: IDSR, IHR JEE, One Health approach, etc. Key developments are underway but world is in a race against time Each major aspect is solvable Did we start on time? No Are we responding too late? Not if action is taken THANK YOU AMR in the African region